Competing In The Sport Of Biotechs, Curis Takes Aim [View article]
Dear Hope4Future,
Evasion of apoptosis, or programmed cell death, is unfortunately only one hallmark of cancer (there are, at least, five more). Recent evidence suggests IAPs may play an important role in the initiation and progression of cancer. Therefore, there is growing interest in targeting IAPS with a number of drugs in development.
Please see, Hanahan, D. and R.A. Weinberg, Hallmarks of cancer: the next generation. Cell, 2011. 144(5): p. 646-74. Gyrd-Hansen, M. and P. Meier, IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer, 2010. 10(8): p. 561-74
Complete Genomics, A Complete Future? [View article]
Clifford A. Reid, Ph.D., is our co-founder and has served as our President, Chief Executive Officer and Chairman since July 2005 and as a member of our board of directors since July 2005. From March 2003 to September 2005, Dr. Reid was Vice President of Collaborative Solutions at Open Text Corporation, a software company. In 1995, Dr. Reid co-founded Eloquent, Inc., a digital video communications company, and served as its Chief Executive Officer until 1999 and as its Chairman until 2003, when it was acquired by Open Text. In 1988, Dr. Reid co-founded Verity, Inc., an enterprise text search engine company, and served as its Vice President of Engineering from 1988 to 1992 and as its Executive Vice President from 1992 to 1993. Dr. Reid received a B.S. in Physics from the Massachusetts Institute of Technology, an M.B.A. from Harvard University and a Ph.D. in Management Science and Engineering from Stanford University.
Seeing Is Believing, The Future Of ACTC [View instapost]
Right. According to their 1st Quarter Conference Call, they have $11 million in cash with an additional $11 million in an equity commitment yet to be drawn down. To raise additional capital, they can either complete an equity financing or initiate a partnership unfortunately at the expense of current shareholders.
Seeing Is Believing, The Future Of ACTC [View instapost]
"That made them suspect that something else may be causing the seeming improvement, such as the anti-rejection drugs she was taking or the placebo effect. But they have since become more confident her improvement is indeed being caused by the cells."
Competing In The Sport Of Biotechs, Curis Takes Aim [View article]
Evasion of apoptosis, or programmed cell death, is unfortunately only one hallmark of cancer (there are, at least, five more). Recent evidence suggests IAPs may play an important role in the initiation and progression of cancer. Therefore, there is growing interest in targeting IAPS with a number of drugs in development.
Please see,
Hanahan, D. and R.A. Weinberg, Hallmarks of cancer: the next generation. Cell, 2011. 144(5): p. 646-74.
Gyrd-Hansen, M. and P. Meier, IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer, 2010. 10(8): p. 561-74
Kind regards,
Ben
Complete Genomics, A Complete Future? [View article]
http://bit.ly/QyshMd
Seeing Is Believing, The Future Of ACTC [View instapost]
Seeing Is Believing, The Future Of ACTC [View instapost]
http://n.pr/wvVsbh